from Breakingviews:

China insurers’ worst habits go almost unchecked

July 26, 2016

The author is a Reuters Breakingviews columnist. The opinions expressed are her own.

from Breakingviews:

Fintech: bigger and dicier for insurers than banks

July 13, 2016

The insurance industry is ripe for technological disruption, but the results may be dicey. Some areas of banking services, notably payments, have been relentlessly targeted by start-up companies since the financial crisis. But nine in 10 insurance executives polled by consultant PwC reckon at least part of their business is at risk over the next five years – a greater proportion than in any other area of finance.

from Breakingviews:

Anbang risks a Year of the Stalking Horse

April 1, 2016

The author is a Reuters Breakingviews columnist.  The opinions expressed are his own.

from Breakingviews:

Politics, not finance, is key question for Anbang

March 31, 2016

The author is a Reuters Breakingviews columnist. The opinions expressed are her own.

from Breakingviews:

Anbang’s U.S. hotel block bookings getting pricey

March 14, 2016

By Kevin Allison and Richard Beales

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Ambac getting right pressure from wrong place

March 3, 2016

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

China web finance craze sows confusion and risk

February 19, 2016

The author is a Reuters Breakingviews columnist. The opinions expressed are her own.

from Breakingviews:

AIG makes late push toward mediocrity

January 26, 2016

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Financial Regulatory Forum:

IMPACT ANALYSIS: Second phase audits of patient-privacy compliance starting under U.S. health agency

January 26, 2016

By Elizabeth Polking, Regulatory Intelligence

(Thomson Reuters Regulatory Intelligence) - Hundreds of U.S. health-care providers over the next three years will be scrutinized for their compliance with patient privacy regulations, as regulators respond to findings of widespread compliance gaps and launch a new round of industry audits.

from Financial Regulatory Forum:

COMMENTARY: Insurance mergers face U.S. regulatory uncertainty despite inversions clarification

December 28, 2015

By Lawrence Hsieh, Practical Law

Although the pharmaceutical industry has drawn a lot of the attention given to corporate inversions, the regulatory environment for these tax-saving corporate relocation transactions also affects insurance mergers.